Nobivac NXT feline FeLV 1 0.5 ml/Dose 25 x 0.5 ml
Key product information
Important product information
Review product information, ingredients, storage, warnings, and other important details before ordering.
Overview
Read the product description and usage details.
Overview
Feline Leukenia vaccine, RNA particle. Adjuvant, preservative, antibiotic and thimerosal free. Nobivac® NXT FeLV is a non-adjuvanted, freeze-dried injectable feline leukemia virus vaccine, utilizing RNA particle technology. The vaccine stimulates expression of the desired antigen to induce a protective immune response against feline leukemia virus, including protection against persistent viremia in cats. This product has been shown to be effective for the vaccination of healthy cats 8 weeks of age or older against feline leukemia virus. Duration of immunity is at least 2 years. For more information regarding efficacy and safety data, go to productdata.aphis.usda.gov. This product has been shown to be effective against persistent viremia in cats exposed to virulent feline leukemia virus.
Product Details
| Approved For | Cat |
| Therapeutic Use | Vaccine |
| Form | Powder for solution |
| Route of Administration | Subcutaneous |
| Strength / Concentration | 0.5 ml/Dose ml/Dose |
| Pack Size | 25 x 0.5 ml |
Safety & Storage
Storage: Refrigerated
Specifications
Review available public product specifications and handling details.
Basic Information
| Brand | Merck |
|---|---|
| Strength | 0.5 ml/Dose ml/Dose |
| Pack Size | 25 x 0.5 ml |
Storage & Shipping
| Shipping Weight | 0.29 kg |
|---|---|
| Storage Conditions | Refrigerated |
Important Notice
Product information is provided for reference only and does not replace veterinary advice. Always follow your veterinarian’s direction for prescription products.
